To explore the viability of hematopoietic stem cells in high doses of ionizing radiation
DOI:
https://doi.org/10.61173/bgtkpn04Keywords:
STAT3, hematopoietic stem cells, ionizing radiationAbstract
Excessive exposure to radiation poses a significant threat to the integrity of our hematopoietic stem cells, which are essential for blood formation. The primary objective of our research is to safeguard the viability of these cells against the onslaught of high-dose radiation. Despite the critical nature of this issue, current literature lacks an in-depth investigation into the mechanisms by which hematopoietic stem cells respond to such intense radiation. To address this gap, we have embarked on a study to modulate the expression levels of the STAT3 protein within hematopoietic stem cells. By employing both gene knockout and overexpression techniques, we aim to elucidate the role of STAT3 in the survival of these cells post-radiation exposure. Our methodology will involve a meticulous enumeration of surviving cells to assess whether the modulation of STAT3 confers a protective advantage against radiation-induced damage.
References
[1] Shao L, Luo Y, Zhou D. Hematopoietic stem cell injury induced by ionizing radiation. Antioxid Redox Signal. 2014 Mar 20;20(9):1447-62. doi: 10.1089/ ars.2013.5635. Epub2014 Feb 10. PMID:24124731; PMCID: PMC3936513.
[2] Dzierzak E, Bigas A. Blood Development: Hematopoietic Stem Cell Dependence and Independence. Cell Stem Cell. 2018 May 3;22(5):639-651. doi:10.1016/j. stem.2018.04.015. PMID:29727679.
[3] Zou S, TongQ, Liu B, Huang W, Tian Y, Fu X. Targeting STAT3 in Cancer Immunotherapy. Mol Cancer. 2020 Sep 24;19(1):145. doi:10.1186/s12943-020-01258-7. PMID:32972405; PMCID: PMC7513516.
[4] Liu Y, Liao S, Bennett S, Tang H, Song D, Wood D, Zhan X, Xu J. STAT3 and its targeting inhibitors in osteosarcoma. Cell Prolif. 2021 Feb;54(2):e12974. doi:10.1111/ cpr.12974. Epub 2020 Dec 31. PMID:33382511; PMCID: PMC7848963.
[5] Hillmer EJ, Zhang H, Li HS, Watowich SS. STAT3 signaling in immunity. Cytokine Growth Factor Rev. 2016 Oct;31:1- 15. doi: 10.1016/j. cytogfr.2016.05.001. Epub 2016 May 9. PMID:27185365; PMCID: PMC5050093.
[6] Savić N, Schwank G. Advances in therapeutic CRISPR/Cas9 genome editing. Transl Res. 2016 Feb;168:15-21. doi: 10.1016/j. trsl.2015.09.008. Epub 2015 Sep 26. PMID:26470680.
[7] Hryhorowicz M, Lipiński D, Zeyland J, Słomski R. CRISPR/ Cas9 Immune System as a Tool for Genome Engineering. Arch Immunol Ther Exp( Warsz). 2017 Jun;65(3):233- 240. doi: 10.1007/s00005-016-0427-5. Epub 2016 Oct 3. PMID:27699445; PMCID: PMC5434172.
[8] Longo PA, Kavran JM, Kim MS, Leahy DJ. Transient mammalian cell transfection with polyethylenimine (PEI). Methods Enzymol. 2013;529:227-40. doi:10.1016/B978-0-12- 418687-3.00018-5. PMID:24011049; PMCID: PMC4012321.
[9] Darnel l JE Jr. STATs and gene regulation. Science. 1997 Sep 12;277(5332):1630-5. doi: 10.1126/ science.277.5332.1630. PMID:9287210.
[10] Ferk F, Mišík M, Al-Serori H, Nersesyan A, Wultsch G, Knasmueller S. The Single- Cell Gel Electrophoresis Genotoxin Sensitivity Assay. Methods Mol Biol.2021;2240:1-12. doi: 10.1007/978-1-0716-1091-6 1. PMID:33423222.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.

This work is licensed under a Creative Commons Attribution 4.0 International License.
